MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 255 - per page Previous page Next page
Order by
Herpclair - indicated for the treatment of herpes simplex virus (HSV) type 1 infections.
Herpclair is a topical composition based on extracts of plants suitably selected to ensure anti-herpes type 1 activity. More
Compositions and Methods for Increasing Recombinant Protein Yields Through the Modification of Cellular Properties
Compositions and methods for improving the growth characteristics of cells engineered to produce biologically active products such as antibodies or glycosylated proteins. More
Enhanced T-cell Activation by Costimulation: An Effective Immunotherapy for Cancer and Infectious Diseases
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and TAAs. More
In Vitro Model for Hepatitis C Virion Production
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
ImmLab's primary product: A Therapeutic Staphylococcal Lysate (SL) as described in our patent 6,929,798 and 7,329,409 granted by the U.S. Patent and Trademark Office
SL is prepared by lysis of S. aureus culture with a polyvalent bacteriophage. More
TNF-alpha Converting Enzyme Inhibitory Agents and Stimulatory Agents
This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More
Cold Fleece Patch
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
Antimicrobial Peptides
A novel selective antimicrobial peptide based on human LL-37 by D-amino acid incorporation. More
Universally Applicable Technology for Inactivation of Enveloped Viruses and Other Pathogenic Microorganisms for Vaccine Development
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
A new treatment for diarrhoea and endotoxaemic shock in bovine (with potential application to other mammals)
A new veterinary medicinal composition designed to maintain the oxygenic consumption, to restore hydric, electrolytic and energetic status, as well as the blood pH in affected mammals. More
Displaying 11..20 of 255 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us